Fluoroalkyl-1,4-benzodiazepinone compounds

Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3, CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and Ra, Rb, y, and z are defined herein. Also disclosed are methods of using su...

Full description

Saved in:
Bibliographic Details
Main Authors O'MALLEY DANIEL, BALOG JAMES AARON, GAVAI ASHVINIKUMAR V, W. SHAN, QUESNELLE CLAUDE A, HAN WENING, DELUCCA GEORGE V, FINK BRIAN E
Format Patent
LanguageEnglish
Published 05.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3, CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
AbstractList Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3, CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
Author GAVAI ASHVINIKUMAR V
DELUCCA GEORGE V
FINK BRIAN E
BALOG JAMES AARON
O'MALLEY DANIEL
QUESNELLE CLAUDE A
HAN WENING
W. SHAN
Author_xml – fullname: O'MALLEY DANIEL
– fullname: BALOG JAMES AARON
– fullname: GAVAI ASHVINIKUMAR V
– fullname: W. SHAN
– fullname: QUESNELLE CLAUDE A
– fullname: HAN WENING
– fullname: DELUCCA GEORGE V
– fullname: FINK BRIAN E
BookMark eNrjYmDJy89L5WTQcsspzS_KT8zJrszRNdQx0U1KzavKT8lMrEotyAQpUUjOzy3IL81LKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGJhZGRmbm5o7GxKgBAC2KKwQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN104822677A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN104822677A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN104822677A3
Notes Application Number: CN201380060053
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150805&DB=EPODOC&CC=CN&NR=104822677A
ParticipantIDs epo_espacenet_CN104822677A
PublicationCentury 2000
PublicationDate 20150805
PublicationDateYYYYMMDD 2015-08-05
PublicationDate_xml – month: 08
  year: 2015
  text: 20150805
  day: 05
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.0008516
Snippet Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Fluoroalkyl-1,4-benzodiazepinone compounds
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150805&DB=EPODOC&locale=&CC=CN&NR=104822677A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQPtd7RMMQUmXtM0XRNT01TdpNTEVF1gVWuZlpwGrGJMQRuFff3MPEJNvCJMI5gYsmB7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHcMOtzcwFTNxcnWNcDfxd9ZzdnZ1tlPzS8IdMktsCo0Mzd3ZGZgBTWjQefsu4Y5gXalFCBXKW6CDGwBQNPySoQYmFLzhBk4nWE3rwkzcPhCJ7yBTGjeKxZh0HLLKc0vyk_Mya7M0TXUMQH6Nq8qHxi9VakFmcBOfKoCaHk46JakYlEGRTfXEGcPXaCl8XAfxjv7IdxnLMbAAtIkwaCQZJlskpiUamGUbGJhYmySlGhknmRpap6aZJAKagmlSTJI4TZHCp-kNAMXKLTAK9lMZRhYSopKU2WBtWtJkhw4WABqxX5T
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQPtd7RMMQUmXtM0XRNT01TdpNTEVF1gVWuZlpwGrGJMQRuFff3MPEJNvCJMI5gYsmB7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHcMOtzcwFTNxcnWNcDfxd9ZzdnZ1tlPzS8IdMktsCo0Mzd3ZGZgNQd2CcFdpTAn0K6UAuQqxU2QgS0AaFpeiRADU2qeMAOnM-zmNWEGDl_ohDeQCc17xSIMWm45pflF-Yk52ZU5uoY6JkDf5lXlA6O3KrUgE9iJT1UALQ8H3ZJULMqg6OYa4uyhC7Q0Hu7DeGc_hPuMxRhYQJokGBSSLJNNEpNSLYySTSxMjE2SEo3MkyxNzVOTDFJBLaE0SQYp3OZI4ZOUZ-D0CPH1iffx9POWZuAChRx4VZupDANLSVFpqiywpi1JkgMHEQB3o4E9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Fluoroalkyl-1%2C4-benzodiazepinone+compounds&rft.inventor=O%27MALLEY+DANIEL&rft.inventor=BALOG+JAMES+AARON&rft.inventor=GAVAI+ASHVINIKUMAR+V&rft.inventor=W.+SHAN&rft.inventor=QUESNELLE+CLAUDE+A&rft.inventor=HAN+WENING&rft.inventor=DELUCCA+GEORGE+V&rft.inventor=FINK+BRIAN+E&rft.date=2015-08-05&rft.externalDBID=A&rft.externalDocID=CN104822677A